IP Library Granted Patent US 9,096,591
Granted Patent B2
US 9,096,591 · App. 13/797,723 · Granted Aug 4, 2015

Tetracyclic compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,096,591
App. No.
13/797,723
Granted
Aug 4, 2015
Kind
B2
Abstract

This disclosure relates to new tetracyclic compounds that may be used to modulate a histamine receptor in an individual. The compounds in one embodiment are tetracyclic [4,3-b]indoles. Pharmaceutical compositions comprising the compounds are also provided, as are methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.

Claims (110)

1. A compound of the Formula (E):

or a salt thereof, wherein:

R 1 is H, hydroxyl, nitro, cyano, halo, substituted or unsubstituted C 1 -C 8 alkyl, substituted or unsubstituted C 2 -C 8 alkenyl, substituted or unsubstituted C 2 -C 8 alkynyl, perhaloalkyl, acyl, acyloxy, carbonylalkoxy, substituted or unsubstituted heterocyclyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted aralkyl, C 1 -C 8 perhaloalkoxy, alkoxy, aryloxy, carboxyl, thiol, thioalkyl, substituted or unsubstituted amino, acylamino, aminoacyl, aminocarbonylamino, aminocarbonyloxy, aminosulfonyl, sulfonylamino, sulfonyl or carbonylalkylenealkoxy;

wherein acyl is selected from the group consisting of H—C(O)—, alkyl-C(O)—, substituted alkyl-C(O)—, alkenyl-C(O)—, substituted alkenyl-C(O)—, alkynyl-C(O)—, substituted alkynyl-C(O)—, aryl-C(O)—, substituted aryl-C(O)—, heteroaryl-C(O)—, substituted heteroaryl-C(O)—, heterocyclic-C(O)—, and substituted heterocyclic-C(O)—;

wherein sulfonylamino is selected from the group consisting of —SO 2 NH 2 —SO 2 NR-alkyl, —SO 2 NR-substituted alkyl, —SO 2 NR-alkenyl, —SO 2 NR-substituted alkenyl, —SO 2 NR-alkynyl, —SO 2 NR-substituted alkynyl, —SO 2 NR-aryl, —SO 2 NR-substituted aryl, —SO 2 NR-heteroaryl, —SO 2 NR-substituted heteroaryl, —SO 2 NR-heterocyclic, and —SO 2 NR-substituted heterocyclic, where R is H or alkyl, or —SO 2 NR 2 , wherein the two R groups are taken together and with the nitrogen atom to which they are attached to form a heterocyclic or substituted heterocyclic ring;

wherein sulfonyl is selected from the group consisting of —SO 2 -alkyl, —SO 2 -substituted alkyl, —SO 2 -alkenyl, —SO 2 -substituted alkenyl, —SO 2 -alkynyl, —SO 2 -substituted alkynyl, —SO 2 -aryl, —SO 2 -substituted aryl, —SO 2 -heteroaryl, —SO 2 -substituted heteroaryl, —SO 2 -heterocyclic, and —SO 2 -substituted heterocyclic;

each R 2a and R 2b is independently H, substituted or unsubstituted C 1 -C 8 alkyl, halo, hydroxyl, alkoxy, cyano, nitro or R 2a and R 2b are taken together with the carbon to which they are attached to form a carbonyl moiety or R 2a and R 2b are taken together with the carbon to which they are attached to form a cycloalkyl moiety;

each R 3a and R 3b is independently H, substituted or unsubstituted C 1 -C 8 alkyl, halo, hydroxyl, alkoxy, cyano, nitro or R 3a and R 3b are taken together with the carbon to which they are attached to form a carbonyl moiety or R 3a and R 3b are taken together with the carbon to which they are attached to form a cycloalkyl moiety;

X 7 , X 8 , X 9 and X 10 are taken together to provide an aromatic moiety selected from the group consisting of:

m and q are independently 0 or 1;

each R 4 , where present, is independently hydroxyl, nitro, cyano, halo, C 1 -C 8 perhaloalkyl, carboxy, substituted or unsubstituted C 1 -C 8 alkyl, substituted or unsubstituted C 2 -C 8 alkenyl, substituted or unsubstituted C 2 -C 8 alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, C 1 -C 8 perhaloalkoxy, C 1 -C 8 alkoxy, aryloxy, carboxyl, carbonylalkoxy, thiol, substituted or unsubstituted heterocyclyl, substituted or unsubstituted aralkyl, thioalkyl, substituted or unsubstituted amino, acylamino, aminoacyl, aminocarbonylamino, aminocarbonyloxy, aminosulfonyl, sulfonylamino, sulfonyl, carbonylalkylenealkoxy, alkylsulfonylamino or acyl;

wherein acyl is selected from the group consisting of H—C(O)—, alkyl-C(O)—, substituted alkyl-C(O)—, alkenyl-C(O)—, substituted alkenyl-C(O)—, alkynyl-C(O)—, substituted alkynyl-C(O)—, aryl-C(O)—, substituted aryl-C(O)—, heteroaryl-C(O)—, substituted heteroaryl-C(O)—, heterocyclic-C(O)—, and substituted heterocyclic-C(O)—;

wherein sulfonylamino is selected from the group consisting of —SO 2 NH 2 —SO 2 NR-alkyl, —SO 2 NR-substituted alkyl, —SO 2 NR-alkenyl, —SO 2 NR-substituted alkenyl, —SO 2 NR-alkynyl, —SO 2 NR-substituted alkynyl, —SO 2 NR-aryl, —SO 2 NR-substituted aryl, —SO 2 NR-heteroaryl, —SO 2 NR-substituted heteroaryl, —SO 2 NR-heterocyclic, and —SO 2 NR-substituted heterocyclic, where R is H or alkyl, or —SO 2 NR 2 , wherein the two R groups are taken together and with the nitrogen atom to which they are attached to form a heterocyclic or substituted heterocyclic ring;

wherein sulfonyl is selected from the group consisting of —SO 2 -alkyl, —SO 2 -substituted alkyl, —SO 2 -alkenyl, —SO 2 -substituted alkenyl, —SO 2 -alkynyl, —SO 2 -substituted alkynyl, —SO 2 -aryl, —SO 2 -substituted aryl, —SO 2 -heteroaryl, —SO 2 -substituted heteroaryl, —SO 2 -heterocyclic, and —SO 2 -substituted heterocyclic;

each R 8a , R 8b , R 8c , R 8d , R 8e and R 8f , where present, is independently H, hydroxyl, C 1 -C 8 alkyl, carboxy, carbonylalkoxy or is taken together with the carbon to which it is attached and a geminal R 8 to form a cycloalkyl moiety or a carbonyl moiety;

each R 10a and R 10b is independently H, substituted or unsubstituted C 1 -C 8 alkyl, halo, hydroxyl, alkoxy, cyano, nitro or R 10a and R 10b are taken together with the carbon to which they are attached to form a carbonyl moiety or R 10a and R 10b are taken together with the carbon to which they are attached to form a cycloalkyl moiety; and

Q is a substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, or substituted or unsubstituted heterocyclyl.

2. The compound of claim 1 , or a salt thereof, wherein X 7 , X 8 , X 9 and X 10 are taken together to provide an aromatic moiety selected from the group consisting of:

3. The compound of claim 1 , or a salt thereof, wherein at least one of R 8a , R 8b , R 8c , R 8d , R 8e and R 8f is hydroxyl, C 1 -C 8 alkyl, carboxy, carbonylalkoxy, or is taken together with the carbon to which it is attached and a geminal R 8(a-f) to form a cycloalkyl moiety or a carbonyl moiety.

4. The compound of claim 1 , or a salt thereof, wherein each R 8a , R 8b , R 8c , R 8d , R 8e and R 8f , where present, is H.

5. The compound of claim 1 , or a salt thereof, wherein at least one of R 8c , R 8d , R 8e and R 8f , where present, is other than H.

6. The compound of claim 1 , or a salt thereof, wherein at least one of R 8e and R 8f is other than H.

7. The compound of claim 6 , or a salt thereof, wherein the compound has at least one R 4 , and wherein each R 4 is independently substituted or unsubstituted C 1 -C 8 alkyl, perhaloalkyl or halo.

8. The compound of claim 7 , or a salt thereof, wherein each R 4 is independently methyl, CH 2 F, CHF 2 , CF 3 , chloro or fluoro.

9. The compound of claim 1 , or a salt thereof, wherein at least one of R 8a , R 8b , R 8c , R 8d , R 8e and R 8f is substituted or unsubstituted C 1 -C 8 alkyl.

10. The compound of claim 1 , or a salt thereof, wherein at least one of R 8a , R 8b , R 8c , R 8d , R 8e and R 8f is methyl.

11. The compound of claim 1 , or a salt thereof, wherein —R 8c R 8d —R 8e R 8f — and the carbons to which they are attached are taken together to form a moiety selected from the group consisting of —CH 2 —C(H)(CH 3 )—, —C(H)(CH 3 )—CH 2 —, —CH 2 —C(CH 3 )(CH 3 )—, —C(CH 2 CH 2 )—CH 2 - and —CH 2 —C(CH 2 CH 2 )—.

12. The compound of claim 1 , or a salt thereof, wherein q is 0, and m is 1.

13. The compound of claim 1 , or a salt thereof, wherein the compound has at least one R 4 , and wherein each R 4 is independently hydroxyl, halo, C 1 -C 8 perhaloalkyl, substituted or unsubstituted C 1 -C 8 alkyl, substituted or unsubstituted C 2 -C 8 alkenyl, substituted or unsubstituted C 2 -C 8 alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, C 1 -C 8 perhaloalkoxy, C 1 -C 8 alkoxy, aryloxy, carboxyl, thiol, carbonylalkoxy, thioalkyl, alkylsulfonylamino or acyl.

14. The compound of claim 1 , or a salt thereof, wherein the compound has at least one R 4 , and wherein each R 4 is independently nitro, cyano, substituted or unsubstituted heterocyclyl, substituted or unsubstituted aralkyl, thioalkyl, substituted or unsubstituted amino, acylamino, aminoacyl, aminocarbonylamino, aminocarbonyloxy, aminosulfonyl, sulfonylamino, sulfonyl, or carbonylalkylenealkoxy.

15. The compound of claim 1 , or a salt thereof, wherein the compound has at least one R 4 , wherein each R 4 is independently substituted or unsubstituted C 1 -C 8 alkyl, perhaloalkyl or halo.

16. The compound of claim 15 , or a salt thereof, wherein each R 4 is independently methyl, CH 2 F, CHF 2 , CF 3 , chloro or fluoro.

17. The compound of claim 1 , or a salt thereof, wherein each R 2a , R 2b , R 3a , R 3b , R 10a and R 10b is independently H, unsubstituted or substituted C 1 -C 8 alkyl, or halo.

18. The compound of claim 17 , or a salt thereof, wherein each R 2a , R 2b , R 3a , R 3b , R 10a and R 10b is H.

19. The compound of claim 1 , or a salt thereof, wherein Q is a substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.

20. The compound of claim 19 , or a salt thereof, wherein Q is selected from the group consisting of:

wherein each R 9 , where present, is independently halo, cyano, nitro, perhaloalkyl, perhaloalkoxy, substituted or unsubstituted C 1 -C 8 alkyl, substituted or unsubstituted C 2 -C 8 alkenyl, substituted or unsubstituted C 2 -C 8 alkynyl, acyl, acyloxy, carbonylalkoxy, thioalkyl, substituted or unsubstituted heterocyclyl, alkoxy, substituted or unsubstituted amino, acylamino, sulfonylamino, sulfonyl, carbonyl, aminoacyl or aminocarbonylamino.

21. The compound of claim 1 , or a salt thereof, wherein Q is substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, or substituted or unsubstituted heterocyclyl.

22. The compound of claim 21 , or a salt thereof, wherein Q is selected from the group consisting of:

wherein each R 9 , where present, is independently halo, cyano, nitro, perhaloalkyl, perhaloalkoxy, substituted or unsubstituted C 1 -C 8 alkyl, substituted or unsubstituted C 2 -C 8 alkenyl, substituted or unsubstituted C 2 -C 8 alkynyl, acyl, acyloxy, carbonylalkoxy, thioalkyl, alkoxy, substituted or unsubstituted amino, acylamino, sulfonylamino, sulfonyl, carbonyl, aminoacyl or aminocarbonylamino.

23. The compound of claim 1 , or a salt thereof, wherein:

R 1 is methyl or ethyl;

each R 8C , R 8d , R 8e and R 8f , where present, is independently H or C 1 -C 8 alkyl;

X 7 is CR 4 where R 4 is H;

X 8 and X 10 are independently CR 4 where R 4 is H or halo;

X 9 is CR 4 where R 4 is halo, methyl, CH 2 F, CHF 2 , CF 3 , or ethyl; and

Q is a substituted or unsubstituted phenyl or a substituted or unsubstituted pyridyl.

24. The compound of claim 23 , or a salt thereof, wherein q is 0 and m is 1.

25. The compound of claim 24 , or a salt thereof, wherein each R 2a , R 2b , R 3a , R 3b , R 10a and R 10b is H.

26. The compound of claim 1 , or a salt thereof, wherein:

R 1 is unsubstituted C 1 -C 8 alkyl;

each of R 2a , R 2b , R 3a , R 3b , R 10a and R 10b is H; and

each R 8a , R 8b , R 8C , R 8d , R 8e and R 8f is independently H, hydroxyl, C 1 -C 8 alkyl, carboxy, carbonylalkoxy, or is taken together with the carbon to which it is attached and a geminal R 8(a-f) to form a cycloalkyl moiety or a carbonyl moiety.

27. The compound of claim 26 , or a salt thereof, wherein q is 0 and m is 1.

28. The compound of claim 27 , or a salt thereof, wherein —R 8c R 8d —R 8e R 8f — and the carbons to which they are attached are taken together to form a moiety selected from the group consisting of —CH 2 —C(H)(CH 3 )—, —C(H)(CH 3 )—CH 2 —, —CH 2 —C(CH 3 )(CH 3 )—, —C(CH 2 CH 2 )—CH 2 - and —CH 2 —C(CH 2 CH 2 )—.

29. The compound of claim 26 , or a salt thereof, wherein Q is a substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.

30. The compound of claim 1 , or a salt thereof, wherein:

R 1 is H, hydroxyl, nitro, cyano, halo, substituted or unsubstituted C 1 -C 8 alkyl, substituted or unsubstituted C 2 -C 8 alkenyl, substituted or unsubstituted C 2 -C 8 alkynyl, perhaloalkyl, acyl, acyloxy, carbonylalkoxy, substituted or unsubstituted heterocyclyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted aralkyl, C 1 -C 8 perhaloalkoxy, alkoxy, aryloxy, carboxyl, thiol, thioalkyl, substituted or unsubstituted amino, acylamino, aminoacyl, aminocarbonylamino, aminocarbonyloxy, aminosulfonyl, sulfonylamino, sulfonyl or carbonylalkylenealkoxy;

each R 2a and R 2b is independently H, substituted or unsubstituted C 1 -C 8 alkyl, halo, hydroxyl, alkoxy, cyano, nitro or R 2a and R 2b are taken together with the carbon to which they are attached to form a carbonyl moiety;

each R 3a and R 3b is independently H, substituted or unsubstituted C 1 -C 8 alkyl, halo, cyano, nitro or R 3a and R 3b are taken together with the carbon to which they are attached to form a carbonyl moiety;

X 7 , X 8 , X 9 and X 10 are taken together to provide an aromatic moiety selected from the group consisting of:

m and q are independently 0 or 1;

each R 4 , where present, is independently hydroxyl, nitro, cyano, halo, C 1 -C 8 perhaloalkyl, substituted or unsubstituted C 1 -C 8 alkyl, substituted or unsubstituted C 2 -C 8 alkenyl, substituted or unsubstituted C 2 -C 8 alkynyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, C 1 -C 8 perhaloalkoxy, C 1 -C 8 alkoxy, aryloxy, carboxyl, thiol, substituted or unsubstituted heterocyclyl, substituted or unsubstituted aralkyl, thioalkyl, substituted or unsubstituted amino, acylamino, aminoacyl, aminocarbonylamino, aminocarbonyloxy, aminosulfonyl, sulfonylamino, sulfonyl, carbonylalkylenealkoxy, alkylsulfonylamino or acyl;

each R 8a , R 8b , R 8C , R 8d , R 8e and R 8 , where present, is independently H, hydroxyl, C 1 -C 8 alkyl, carboxy, carbonylalkoxy or is taken together with the carbon to which it is attached and a geminal R 8 to form a cycloalkyl moiety or a carbonyl moiety;

each R 10a and R 10b is independently H, substituted or unsubstituted C 1 -C 8 alkyl, halo, hydroxyl, alkoxy, or R 10a and R 10b are taken together with the carbon to which they are attached to form a carbonyl moiety; and

Q is a substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkenyl, or substituted or unsubstituted heterocyclyl.

31. The compound of claim 1 , or a salt thereof, wherein the compound is selected from the group consisting of:

Compound

No.

Structure

 11

 12

 14

 15

168

169

170

175

176

177

178

181

182

183

185

210

213

214

259H

260H

261H

273H

276H

291

346

347

348

353

355

482

484

541

544

546

547

548

32. A pharmaceutical composition comprising a compound according to claim 1 , or a salt thereof, and a pharmaceutically acceptable carrier.

33. A kit comprising a compound according to claim 1 , or a salt thereof, and instructions for use.

34. A pharmaceutical composition comprising a compound according to claim 26 , or a salt thereof, and a pharmaceutically acceptable carrier.

35. A kit comprising a compound according to claim 26 , or a salt thereof, and instructions for use.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Sep 28, 2016
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: MEDIVATION PROSTATE THERAPEUTICS, INC.; MEDIVATION TECHNOLOGIES, INC.
Reel/Frame 040181/0177 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 4, 2015
From: MEDIVATION TECHNOLOGIES, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036553/0925 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2015
From: HUNG, DAVID T.; PROTTER, ANDREW A.; JAIN, RAJENDRA P.; DUGAR, SUNDEEP; CHAKRAVARTY, SARVAJIT
To: MEDIVATION TECHNOLOGIES, INC.
Reel/Frame 035253/0754 →